Universal Health Services Reports 10.8% Revenue Growth to $15.83 Billion for Fiscal Year 2024

Universal Health Services, Inc. (UHS) reported a significant increase in financial performance for the fiscal year ending December 31, 2024, with net revenues rising by 10.8% to $15.83 billion, compared to $14.28 billion in 2023. This growth was primarily driven by a $1.32 billion increase in revenues from acute care and behavioral health operations, which accounted for 56% of total revenues, while behavioral health facilities contributed 44%. The company’s income before income taxes surged by 59% to $1.50 billion, reflecting strong operational performance across its facilities.

In terms of operational metrics, UHS operated 359 inpatient facilities and 60 outpatient facilities across 39 states, Washington D.C., the United Kingdom, and Puerto Rico as of February 2025. The company reported an increase in patient admissions and days, with acute care hospital admissions rising by 3.1% and behavioral health admissions increasing by 1.0%. The average length of stay in acute care facilities was 4.8 days, while behavioral health facilities reported an average stay of 13.5 days. The occupancy rates for both segments remained stable, indicating effective utilization of resources.

Strategically, UHS has focused on expanding its operations through acquisitions and partnerships. The company has been actively involved in enhancing its service offerings, particularly in outpatient care, to adapt to market trends favoring less intensive care settings. In 2024, UHS also made significant investments in capital expenditures, totaling approximately $944 million, aimed at upgrading facilities and expanding services. The company’s commitment to quality care and operational efficiency is evident in its ongoing recruitment efforts for qualified medical personnel and the implementation of cost control measures.

The filing also highlighted the challenges posed by regulatory changes and market conditions. UHS is particularly sensitive to fluctuations in Medicaid and Medicare funding, with potential reductions in federal funding for state Medicaid programs posing a risk to future revenues. The company anticipates that changes in healthcare legislation and reimbursement policies could impact its financial performance. Despite these challenges, UHS remains optimistic about its growth trajectory, supported by a robust operational framework and strategic initiatives aimed at enhancing service delivery and patient care.

Looking ahead, UHS plans to continue its focus on expanding its footprint and improving operational efficiencies. The company expects to invest between $850 million and $1 billion in capital expenditures in 2025, which will include renovations and new facility constructions. UHS aims to leverage its strong market position and operational capabilities to navigate the evolving healthcare landscape while maintaining its commitment to delivering high-quality care to its patients.